Heidelberg Pharma AG Statistics

Total Valuation

LON:0QW5 has a market cap or net worth of GBP 111.00 million. The enterprise value is 86.02 million.

Market Cap	111.00M
Enterprise Value	86.02M

Important Dates

The next estimated earnings date is Thursday, July 10, 2025.

Earnings Date	Jul 10, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.02%
Shares Change (QoQ)	+8.17%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	9.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	19.51
PB Ratio	4.33
P/TBV Ratio	6.07
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.34
EV / Sales	14.71
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.45

Financial Position

The company has a current ratio of 5.95, with a Debt / Equity ratio of 0.01.

Current Ratio	5.95
Quick Ratio	4.42
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	-154.82

Financial Efficiency

Return on equity (ROE) is -48.33% and return on invested capital (ROIC) is -31.65%.

Return on Equity (ROE)	-48.33%
Return on Assets (ROA)	-20.82%
Return on Invested Capital (ROIC)	-31.65%
Return on Capital Employed (ROCE)	-41.40%
Revenue Per Employee	54,172
Profits Per Employee	-153,295
Employee Count	105
Asset Turnover	0.10
Inventory Turnover	0.16

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -11.71% in the last 52 weeks. The beta is -0.28, so LON:0QW5's price volatility has been lower than the market average.

Beta (5Y)	-0.28
52-Week Price Change	-11.71%
50-Day Moving Average	2.52
200-Day Moving Average	3.73
Relative Strength Index (RSI)	49.44
Average Volume (20 Days)	77

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0QW5 had revenue of GBP 5.69 million and -16.10 million in losses. Loss per share was -0.35.

Revenue	5.69M
Gross Profit	4.21M
Operating Income	-18.13M
Pretax Income	-16.10M
Net Income	-16.10M
EBITDA	-17.52M
EBIT	-18.13M
Loss Per Share	-0.35

Full Income Statement

Balance Sheet

The company has 24.43 million in cash and 136,220 in debt, giving a net cash position of 24.30 million.

Cash & Cash Equivalents	24.43M
Total Debt	136,220
Net Cash	24.30M
Net Cash Per Share	n/a
Equity (Book Value)	25.63M
Book Value Per Share	0.55
Working Capital	32.86M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -24.57 million and capital expenditures -378,706, giving a free cash flow of -24.95 million.

Operating Cash Flow	-24.57M
Capital Expenditures	-378,706
Free Cash Flow	-24.95M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 74.01%, with operating and profit margins of -318.71% and -282.98%.

Gross Margin	74.01%
Operating Margin	-318.71%
Pretax Margin	-282.98%
Profit Margin	-282.98%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:0QW5 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.02%
Shareholder Yield	-0.02%
Earnings Yield	-14.50%
FCF Yield	-22.48%

Stock Splits

The last stock split was on November 7, 2017. It was a forward split with a ratio of 1.0464082038.

Last Split Date	Nov 7, 2017
Split Type	Forward
Split Ratio	1.0464082038

Scores

LON:0QW5 has an Altman Z-Score of -5.26. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.26
Piotroski F-Score	n/a